Navigation Links
The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference
Date:10/29/2009

MISSION VIEJO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it will participate in the Oppenheimer & Co. 20th Annual Healthcare Conference on November 3-4, 2009 in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO)

Christopher Christensen, the company's president and chief executive officer, Suzanne D. Snapper, the company's chief financial officer, and Gregory K. Stapley, the company's Vice President and General Counsel, will discuss the company's operations, growth strategy and related information on Wednesday, November 4, 2009 at 3:20 p.m. Eastern Time.

A live audio webcast of the company's presentation will be accessible at http://www.veracast.com/webcasts/opco/healthcare09/48212372.cfm. A recording of the webcast will be available at the same URL until February 2, 2010.

About Ensign(TM)

The Ensign Group, Inc.'s operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, hospice care, physical, occupational and speech therapies, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients at 73 care facilities in California, Arizona, Texas, Washington, Utah, Idaho and Colorado. More information about Ensign is available at www.ensigngroup.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

The presentation and webcast may include forward-looking statements that are based on management's current expectations, assumptions and beliefs about the company's business, financial performance, operating results, industry and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the company's actual results to materially and adversely differ from those expressed in any forward-looking statement.

Risks and uncertainties affect Ensign's business, industry and common stock. Attendees and listeners should not place undue reliance on any forward-looking statements and are encouraged to review the company's periodic filings with the Securities and Exchange Commission, including the company's recently filed Forms 10-K and 10-Q, for a more complete discussion of the risks and other factors that could affect Ensign's business, prospects and any forward-looking statements. Except as required by federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release or the webcast.

SOURCE The Ensign Group, Inc.


'/>"/>
SOURCE The Ensign Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Ensign Group Schedules Third Quarter 2009 Earnings Call for Tuesday, November 3, 2009
2. The Ensign Group Acquires Three Utah Skilled Nursing Facilities
3. The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business
4. The Ensign Group, Inc. Declares Quarterly Dividend
5. The Ensign Group Reports Second Quarter 2009 Earnings of $0.39 per Share; Reaffirms 2009 EPS Guidance
6. The Ensign Group Announces Appointment of Healthcare Industry Leader to Board of Directors
7. The Ensign Group Declares Quarterly Dividend
8. The Ensign Group Announces the Retirement of CFO Alan J. Norman; Names Suzanne D. Snapper as New Chief Financial Officer
9. The Ensign Group to Present at the Eighth Annual JMP Securities Research Conference on May 19th
10. The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance
11. The Ensign Group Schedules First Quarter 2009 Earnings Call for Thursday, May 7, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are ... saves lives. However, if one isn’t accessible in certain locations, the risk of ... I came up with this idea," said an inventor from Ridgecrest, Calif. , ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, ... Educational Leadership and Administration at St. Thomas University in Miami, Florida, was selected ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... emergency rooms is celebrating the one year anniversary of its Houston-Fallbrook facility. ... said Dr. Otinwa, Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It ...
(Date:9/22/2017)... Diego, CA (PRWEB) , ... September 22, 2017 ... ... offer groceries, wearable, and more products at customers’ doorstep. According to Smart Mart, ... Smart Mart has stated to offer wearable, and customers can find clothing at ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , ... wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral ... concluded its meeting with the U.S. Food and Drug ... formulation. At the ... pathway for submission of ORMD-0801, would be a Biologics ...
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
Breaking Medicine Technology: